GENUINE Improvements: Ublituximab Plus Ibrutinib for CLL GENUINE Improvements: Ublituximab Plus Ibrutinib for CLL

Chronic lymphocytic leukemia (CLL) expert Jennifer R. Brown, MD, discusses the recently published GENUINE trial and its implications for treating high-risk patients.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news